"The greatest glory in living lies not in never falling, but in rising every time we fall." – Nelson Mandela
Tirzepatide is a once-weekly injectable drug approved for the management of type 2 diabetes. It works by activating both GIP and GLP-1 receptors, helping to improve blood glucose control while also promoting substantial weight loss. Its effects on appetite regulation and delayed gastric emptying contribute to reduced caloric intake and better glycemic outcomes.
Tirzepatide is a once-weekly injectable drug approved for the management of type 2 diabetes. It works by activating both GIP and GLP-1 receptors, helping to improve blood glucose control while also promoting substantial weight loss. Its effects on appetite regulation and delayed gastric emptying contribute to reduced caloric intake and better glycemic outcomes.
Reviews
There are no reviews yet.